A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to track changes in overactive bladder (OAB) medical regimen and/or OAB medication dosage requirements.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)

NCT01099345

Bladder Function

TERMINATED

Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects

NCT01029015

Bladder Function

COMPLETED

A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients

NCT00840645

Urinary Bladder, Overactive

COMPLETED PHASE3

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01043666

Urinary Bladder, Overactive

COMPLETED PHASE3

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01604928

Urinary Bladder, Overactive

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects will complete a study specific survey questionnaire at Screening and the Month 1 through Month 6 visits. Subjects will be followed for 6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overactive Bladder (OAB)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects with Overactive Bladder (OAB)

Combination of new OAB subjects and existing subjects on OAB medication

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has overactive bladder as determined by their prescribing physician
* Subject is currently receiving pharmacotherapy for overactive bladder
* Subject is willing to comply with required protocol/study requirements

Exclusion Criteria

* Subject has a history of a clinically significant illness or medical condition prior to screening that would preclude participation in the study
* Male subjects with Lower Urinary Tract Symptoms (LUTS) or Bladder Outlet Obstruction (BOO)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No